Literature DB >> 10614258

Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race.

D A Sclar1, L M Robison1, T L Skaer1, W M Dickson2, C M Kozma2, C E Reeder2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10614258     DOI： 10.1177/014572179902500406

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN： 0145-7217            Impact factor:   2.140


× No keyword cloud information.
  11 in total

1.  Racial differences in adherence to cardiac medications.

Authors:  Hyasmine Charles; Chester B Good; Barbara H Hanusa; Chung-Chou H Chang; Jeff Whittle
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

2.  How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.

Authors:  Thomas Wilke; Antje Groth; Sabrina Mueller; Dallas Reese; Roland Linder; Susanne Ahrens; Frank Verheyen
Journal:  Eur J Health Econ       Date:  2012-07-20

3.  Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes.

Authors:  Heather F de Vries McClintock; Knashawn H Morales; Dylan S Small; Hillary R Bogner
Journal:  Behav Med       Date:  2014-10-10       Impact factor: 3.104

4.  Time use in clinical encounters: are African-American patients treated differently?

Authors:  M N Oliver; M A Goodwin; R S Gotler; P M Gregory; K C Stange
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

5.  Randomised controlled trial of structured personal care of type 2 diabetes mellitus.

Authors:  N F Olivarius; H Beck-Nielsen; A H Andreasen; M Hørder; P A Pedersen
Journal:  BMJ       Date:  2001-10-27

6.  Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans.

Authors:  Nancy Kim; Joseph Agostini; Amy Justice
Journal:  J Pharm Technol       Date:  2009-07

7.  Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

Authors:  Julie A Schmittdiel; Connie S Uratsu; Andrew J Karter; Michele Heisler; Usha Subramanian; Carol M Mangione; Joe V Selby
Journal:  J Gen Intern Med       Date:  2008-03-04       Impact factor: 5.128

8.  Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).

Authors:  Laura N McEwen; Dori Bilik; Susan L Johnson; Jeffrey B Halter; Andrew J Karter; Carol M Mangione; Usha Subramanian; Beth Waitzfelder; Jesse C Crosson; William H Herman
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 19.112

Review 9.  50% adherence of patients suffering chronic conditions--where is the evidence?

Authors:  Tim Mathes; Dawid Pieper; Sunya-Lee Antoine; Michaela Eikermann
Journal:  Ger Med Sci       Date:  2012-11-13

10.  Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.

Authors:  Godfrey Mutashambara Rwegerera
Journal:  Pan Afr Med J       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.